Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA yield high or low?
The EBITDA yield of 5000.00% is in line with its 1-year average of 5000.00%, near the low end of its 1-year range (5000.00%–10000.00%).
As of Friday, August 28, 2026.
EBITDA YIELD
5000.00%
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.92%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
+84359.46%
vs the sector median at left
PDS Biotechnology Corporation
Market Cap
$11.79M
EBITDA Yield
5000.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.23B
EBITDA Yield
19.84%
TTM Avg
13.91%
3Y Avg
5.94%
5Y Avg
6.80%
Market Cap
$3.06B
EBITDA Yield
2.95%
TTM Avg
2.89%
3Y Avg
2.14%
5Y Avg
2.14%
Market Cap
$5.40B
EBITDA Yield
5.81%
TTM Avg
6.29%
3Y Avg
5.14%
5Y Avg
4.71%
Market Cap
$6.43B
EBITDA Yield
1.22%
TTM Avg
1.72%
3Y Avg
1.16%
5Y Avg
1.16%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | 5000.00% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $492.43M | 4.12% | 6.94% | 7.35% | 6.54% |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | 7.09% | 3.69% | 1.78% | 1.78% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 19.84% | 13.91% | 5.94% | 6.80% |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 2.95% | 2.89% | 2.14% | 2.14% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 4.37% | 4.14% | 3.09% | 2.44% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 5.81% | 6.29% | 5.14% | 4.71% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | 1.22% | 1.72% | 1.16% | 1.16% |
| Chemed Corporation (CHE)vs › | $6.84B | 5.68% | 6.49% | 5.45% | 5.41% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2026-08-28 | 5000.00% |
| 2026-08-27 | 5000.00% |
| 2026-08-26 | 5000.00% |
| 2026-08-25 | 5000.00% |
| 2026-08-24 | 5000.00% |
| 2026-08-21 | 5000.00% |
| 2026-08-20 | 5000.00% |
| 2026-08-19 | 10000.00% |
| 2026-08-18 | 5000.00% |
| 2026-08-17 | 5000.00% |
| 2026-08-14 | 5000.00% |
| 2026-08-13 | 5000.00% |
